9 January 2023 - This past year featured many significant developments in the prescription drug policy area, most notably the passage of significant prescription drug pricing reform legislation and a range of developments involving the FDA's accelerated approval program. 

In this post, I review five key developments from the past year and offer five items to watch for in 2023.

Read Health Affairs article